|Articles|February 11, 2022
- Pharmaceutical Commerce - February 2022
- Volume 17
- Issue 1
Pharmaceutical Commerce - February 2022 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Commerce February 2022 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 4 years ago
A Lowdown on Logisticsalmost 4 years ago
The Shifting Course in Logistics Supportalmost 4 years ago
How 3PLs Can Up Their Pharma Gamealmost 4 years ago
For Industry in Flux, is M&A Jolt in Store?almost 4 years ago
CAR-T Therapies: Three Supply Chain Considerationsalmost 4 years ago
The Risk of Doubling Down on Pharmaalmost 4 years ago
Striving for Authentic, Transparent Track and Tracealmost 4 years ago
2022 Pharma 3PL Service Provider Directoryalmost 4 years ago
Booster Rollout Lessons for Pharmaalmost 4 years ago
Assessing Adoption of Hybrid DtP ModelsNewsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
The Great Repricing: How Pharma Must Evolve for Three Diverging Payer Economies
2
The Longer-Term Impact of MFN Pricing
3
The ROI Moment Pharma Keeps Missing: Point-of-Care as Revenue Protection
4
Trade & Channel Strategies 2025: The $405 Billion Patent Cliff Demands Partnership and Adaptive Market Access Strategies
5
